GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | CYP3A4 | affects metabolic processing | EXP | | 6480464 | CTD | CYP3A4 protein affects the metabolism of Verapamil | PMID:15286053 PMID:15692829 PMID:16013069 | CYP3A4 | decreases activity | EXP | | 6480464 | CTD | Verapamil results in decreased activity of CYP3A4 protein | PMID:15689501 PMID:15860655 PMID:21915887 | CYP3A4 | multiple interactions | EXP | | 6480464 | CTD | [Verapamil results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; naringin inhibits the reaction [CYP3A4 protein affects the metabolism of Verapamil]; Verapamil inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Verapamil inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 6 beta-hydroxytestosterone]; Verapamil inhibits the reaction [CYP3A4 protein results in increased metabolism of Midazolam]; Verapamil inhibits the reaction [CYP3A4 protein results in increased metabolism of Testosterone]; Verapamil inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] | PMID:16013069 PMID:19299527 PMID:21915887 PMID:25455453 | |
Go Back to source page | Continue to Ontology report |